Aa
Aa
A
A
A
Close
798555 tn?1292787551

Never read this before........

Using the TPT technology, an injection called VGV-L has been developed to treat Lyme disease, an illness that saw a 100% increase in CDC-confirmed cases from 1991 to 2006. Animal studies have been completed with positive results. We have completed a pre-IND meeting with the FDA for a proposed clinical development program, including a clinical trial.

The early research in this area was supported by grants from two not-for-profit organizations that saw the promise in our approach helping enable the Company to reach this phase of development. The proposed therapy, like several others in our R&D pipeline, is based on TPT and uses synthetic peptides to render pro-inflammatory cells vulnerable to the body’s natural containment protocols

http://www.vglifesciences.com/development/#developmental-studies
2 Responses
Sort by: Helpful Oldest Newest
1763947 tn?1334055319
I would also be interested in knowing more info
Helpful - 0
Avatar universal
Hmm, targeted peptide technology.  I would have to know more about just what peptides they're targeting and in what manner before getting in line.
Helpful - 0
Have an Answer?

You are reading content posted in the Lyme Disease Community

Top Infectious Diseases Answerers
1415174 tn?1453243103
CA
Learn About Top Answerers
Didn't find the answer you were looking for?
Ask a question
Popular Resources
Fearing autism, many parents aren't vaccinating their kids. Can doctors reverse this dangerous trend?
Can HIV be transmitted through this sexual activity? Dr. Jose Gonzalez-Garcia answers this commonly-asked question.
A breakthrough study discovers how to reduce risk of HIV transmission by 95 percent.
Dr. Jose Gonzalez-Garcia provides insight to the most commonly asked question about the transfer of HIV between partners.
Before your drop a dime at the pharmacy, find out if these popular cold and flu home remedies are a wonder or a waste
Fend off colds and the flu with these disease-fighting foods